Neuro-Bio is delighted to welcome Adam Khan as Student Scientist. Adam is a second-year pharmacology undergraduate at the University of Liverpool. He has a keen interest in drug action, neuropharmacology and the cell signalling pathways underlying neurodegeneration....
We are delighted to announce a press release between Unilever and Neuro-Bio sharing the following : Unilever and Neuro-Bio discover a novel marker of skin aging of possible relevance to Alzheimer’s disease. In a pioneering discovery, scientists at Unilever and...
Neuro-Bio is delighted to welcome Marni Rajput as Executive Assistant to the CEO. Marni is excited and grateful to be given the opportunity to join the team at Neuro Bio. She is currently studying Biomedical science at university and strongly believe this course has...
We are delighted to share that Neuro-Bio’s manuscript titled “A novel bioactive peptide, T14, selectively activates mTORC1 signalling: therapeutic implications for neurodegeneration and other rapamycin-sensitive applications”, has been accepted for...
We are pleased to share that Baroness Professor Susan Greenfield, CEO of Neuro-Bio was interviewed by impactful Spanish newspaper “El Periodico”. You can read and watch the interview that echoes the important message and research regarding Alzheimer’s, below :...
Neuro-Bio is delighted to welcome Amelia Ghanea-Hercock as Student Scientist. Amelia is a second-year Neuroscience undergraduate at the University of Bristol. During this time, she has also been a Research Assistant and Founder’s Associate at a London-based...
